Ophthalmology Drugs Market is Forecast to Grow at $26 billion in 2022 Ophthalmology Drugs Market is Forecast to 2022 | Page 4

2.5 Epidemiology Patterns; Prevalence, Patient Segmentation, and Diagnostic and Treatment
Usage Rates 19
2.5.1 Glaucoma 20
2.5.2 Age-Related Macular Degeneration 21
2.5.3 Diabetic Macular Edema 22
2.5.4 Diabetic Retinopathy 22
2.5.5 Dry Eye Syndrome 24
2.6 Treatment 26
3 Key Marketed Products 29
3.1 Overview 29
3.2 Lucentis (ranibizumab) 29
3.3 Eylea (aflibercept) 30
3.4 Avastin (bevacizumab) 31
Access This Full Report @ http://www.radiantinsights.com/research/global-
ophthalmology-drugs-market-to-2022
3.5 Restasis (cyclosporine) 32
3.6 Alphagan (brimonidine tartrate) 34
3.7 Lumigan (bimatoprost) 35
3.8 Xalatan (latanoprost) 36
4 Pipeline Landscape Assessment 38
4.1 Overview 38
4.2 Pipeline Development Landscape 38
4.3 Mechanisms of Action in the Pipeline 41
4.4 Clinical Trials 44
Follow Us: